|
Hot Stocks
| ShowHide Related Items >><< - 02/01/23
- Puma's Nerlynx included in NCCN guidelines for HER2-positive breast cancer
- 12/07/22
- Puma Biotechnology presents updated findings from TBCRC-022 trial
- 08/05/22 H.C. Wainwright
- Puma Biotechnology price target lowered to $8 from $12 at H.C. Wainwright
- 05/04/23
- Puma Biotechnology reports Q1 adjusted EPS 9c, consensus (7c)
- 03/02/23
- Puma Biotechnology reports Q4 EPS (7c), consensus 0c
|
|
Hot Stocks
| ShowHide Related Items >><< - 05/18/23
- Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims
- 05/18/23
- Regeneron 'applauds' Supreme Court's striking down Amgen's patent claims
- 05/18/23
- Supreme Court upholds Sanofi PCSK9 drug patent victory over Amgen
- 05/18/23
- Supreme Court upholds Sanofi patent victory over Amgen
- 06/01/23 Wells Fargo
- Wells says Coherus' Humira biosimilar pricing 'actually good news' for AbbVie
- 05/16/23 Stifel
- Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel
- 05/16/23 Jefferies
- Jefferies thinks Amgen-Horizon deal still gets done after 'speed bump'
- 05/03/23 Mizuho
- Amgen price target raised to $214 from $208 at Mizuho
- 04/27/23
- Amgen raises FY23 adjusted EPS view to $17.60-$18.70 from $17.40-$18.60
- 04/27/23
- Amgen reports Q1 adjusted EPS $3.98, consensus $3.85
- 04/27/23
- Notable companies reporting after market close
- 03/01/23
- Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09
- 05/23/23
- Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports
- 05/17/23
- Regeneron CEO backs regulators attempt to block Amgen deal, FT reports
- 05/16/23
- FTC will sue to block Horizon Therapeutics takeover by Amgen, Bloomberg says
- 05/15/23
- FTC looks to block Horizon Therapeutics deal with Amgen, Capitol Forum says
- 05/16/23
- What You Missed On Wall Street On Tuesday
- 05/16/23
- What You Missed On Wall Street This Morning
- 05/16/23
- Fly Intel: Pre-market Movers
- 04/27/23
- Fly Intel: After-Hours Movers
- 04/05/23
- Early notable gainers among liquid option names on April 5th
- 02/17/23
- Early notable gainers among liquid option names on February 17th
- 01/31/23
- Amgen options imply 3.2% move in share price post-earnings
|
|
Hot Stocks
| ShowHide Related Items >><< - 06/03/23
- Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO
- 06/03/23
- Replimune presents RP1 data from IGNYTE trial at ASCO
- 05/30/23
- Bristol-Myers' repotrectinib application in lung cancer accepted by FDA
- 05/26/23
- Bristol-Myers reports CHMP opinion recommending approval for Opdivo combination
- 05/01/23 Barclays
- Bristol-Myers price target lowered to $65 from $66 at Barclays
- 04/28/23 Credit Suisse
- Bristol-Myers price target lowered to $72 from $78 at Credit Suisse
- 04/21/23 BofA
- Bristol-Myers price target raised to $85 from $82 at BofA
- 04/20/23 H.C. Wainwright
- Legend Biotech price target raised to $77 from $66 at H.C. Wainwright
- 04/27/23
- Bristol-Myers backs FY23 adjusted EPS view $7.95-$8.25, consensus $8.06
- 04/27/23
- Bristol-Myers reports Q1 adjusted EPS $2.05, consensus $1.97
- 04/26/23
- Notable companies reporting before tomorrow's open
- 01/04/23
- Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/02/23
- Fly Intel: Pre-market Movers
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/10/23
- Bristol Myers Squibb put volume heavy and directionally bearish
- 02/24/23
- Bristol Myers Squibb put volume heavy and directionally bearish
|
|
Hot Stocks
| ShowHide Related Items >><< - 05/10/23
- Cerevel Therapeutics appoints Susan Altschuller as CFO
- 05/03/23
- ImmunoGen reports 'positive' results from Phase 3 MIRASOL trial
- 04/28/23
- ImmunoGen raises FY23 revenue excluding ELAHERE view to $45M-$50M
- 04/24/23
- ImmunoGen names Isabel Kalofonos as Chief Commercial Officer
- 05/03/23 Piper Sandler
- ImmunoGen upgraded to Overweight at Piper after 'overwhelmingly positive' data
- 05/03/23 H.C. Wainwright
- H.C. Wainwright reiterates Buy on ImmunoGen following MIRASOL 'homerun'
- 05/03/23 Piper Sandler
- ImmunoGen upgraded to Overweight from Neutral at Piper Sandler
- 05/03/23 Guggenheim
- ImmunoGen's MIRASOL trial results represent best-case scenario, says Guggenheim
- 04/28/23
- ImmunoGen reports Q1 EPS (16c), consensus (25c)
- 03/01/23
- ImmunoGen sees FY23 revenue $30M-$35M, consensus $117.67M
- 03/01/23
- ImmunoGen reports Q4 EPS (23c), consensus (30c)
|
|
Hot Stocks
| ShowHide Related Items >><< - 06/01/23
- Summit Therapeutics: Ivonescimab updated data to be featured at ASCO 2023
- 05/09/23
- Summit Therapeutics doses first patient in HARMONi study
- 05/03/23
- Summit Therapeutics announces initial indications for clinical trials for SMT112
- 01/20/23
- Summit Therapeutics closes deal with Akeso to in-license ivonescimab
- 12/08/22
- Biotech Alert: Searches spiking for these stocks today
- 05/24/23
- Unusually active option classes on open May 24th
- 03/15/23
- Largest borrow rate increases among liquid names
- 03/08/23
- Largest borrow rate increases among liquid names
- 01/09/23
- Largest borrow rate increases among liquid names
|
|
Hot Stocks
| ShowHide Related Items >><< - 06/03/23
- AstraZeneca interim analysis of DUO-O trial shows statistically significant PFS
- 06/02/23
- AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial
- 06/02/23
- AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial
- 06/01/23
- AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer
- 05/26/23 Argus
- AstraZeneca price target lowered to $80 from $85 at Argus
- 05/09/23 Berenberg
- AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
- 04/28/23 JPMorgan
- AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
- 04/13/23 Argus
- AstraZeneca price target raised to $85 from $75 at Argus
- 04/27/23
- AstraZeneca sees FY23 core EPS up high single to low double-digit percentage
- 04/27/23
- AstraZeneca reports Q1 core EPS $1.92, consensus $1.07
- 02/09/23
- AstraZeneca sees FY23 core EPS up high single to low double-digit percentage
- 02/09/23
- AstraZeneca reports Q4 core EPS $1.38, consensus $1.35
- 05/26/23
- Health authorities to target next COVID shot to new strain, WSJ says
- 05/19/23
- Astra China head says company seeks to 'love the Communist Party,' Reuters says
- 05/04/23
- AstraZeneca chair says increasing CEO's pay wards of rivals, FT reports
- 04/06/23
- GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says
- 04/11/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/05/23
- What You Missed On Wall Street On Wednesday
- 04/05/23
- What You Missed On Wall Street This Morning
- 02/09/23
- What You Missed On Wall Street This Morning
- 05/26/23
- Unusually active option classes on open May 26th
- 05/18/23
- Unusually active option classes on open May 18th
- 05/09/23
- AstraZeneca put volume heavy and directionally bearish
- 04/27/23
- Unusually active option classes on open April 27th
|
|
Hot Stocks
|
G1 Therapeutics presented… ShowHide Related Items >><< - 05/22/23
- G1 Therapeutics appoints Monica Thomas as Chief Compliance Officer
- 05/16/23
- G1 confirms risk of myelosuppressive events for patients receiving chemotherapy
- 05/10/23
- G1 Therapeutics announces new results from Phase 2 trial of trilaciclib
- 05/03/23
- G1 Therapeutics sees FY23 COSELA net revenue $50M-$60M
- 01/30/23 JPMorgan
- G1 Therapeutics upgraded to Neutral into data catalysts at JPMorgan
- 01/30/23 JPMorgan
- G1 Therapeutics upgraded to Neutral from Underweight at JPMorgan
- 01/04/23 EF Hutton
- G1 Therapeutics initiated with a Buy at EF Hutton
- 01/03/23 Needham
- G1 Therapeutics named as Top Pick, added to Conviction list at Needham
- 05/03/23
- G1 Therapeutics reports Q1 EPS (53c), consensus (64c)
- 03/01/23
- G1 Therapeutics reports Q4 EPS (73c), consensus (84c)
|
|
Periodicals
| ShowHide Related Items >><< - 06/01/23
- Par Pacific completes acquisition of Exxon Mobil Billings refinery
- 06/01/23
- Nucor enters into carbon capture and storage agreement with Exxon Mobil
- 05/22/23
- Chord Energy to acquire assets in the Williston Basin for $375M
- 05/02/23
- TechnipFMC awarded large subsea contract for ExxonMobil Guyana's Uaru project
- 05/25/23
- TechnipFMC awarded significant contract by Shell for Dover development
- 05/04/23
- Shell announces Q1 interim dividend of 28.75c
- 05/04/23
- Shell sees FY23 cash capital expenditure $23B-$27B
- 05/04/23
- Shell reports Q1 adjusted EPS $1.39, consensus $2.11
- 05/22/23
- Chevron to acquire PDC Energy in $6.3B all-stock transaction
- 05/15/23
- Berkshire Hathaway takes stake in Capital One, exits RH
- 05/15/23
- Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron
- 04/28/23
- Chevron expects to repurchase $4.375B in shares in Q2
- 05/26/23
- ConocoPhillips to also pay contigent payments of up to $325M
- 05/26/23
- ConocoPhillips buying remaining 50% interest in Surmont from TotalEnergies EP
- 05/26/23
- ConocoPhillips to buy remaining 50% interest in Surmont for $3B
- 05/26/23
- ConocoPhillips exercising preemption right to buy 50% interest in Surmont
- 05/31/23
- BP selects Honeywell's Ecofining technology to support production of SAF
- 05/17/23
- Justice Department announces $40M Clean Air Act settlement with BP
- 05/10/23
- TravelCenters of America stockholders approve BP transaction
- 05/02/23
- BP down 5% in pre-market after Q1 earnings, FY23 capex outlook update
- 05/04/23 Credit Suisse
- BP price target lowered to 610 GBp from 630 GBp at Credit Suisse
- 05/04/23 Berenberg
- BP price target lowered to 560 GBp from 590 GBp at Berenberg
- 05/03/23 DZ Bank
- BP downgraded to Hold from Buy at DZ Bank
- 05/03/23 AlphaValue/Baader
- BP upgraded to Add from Sell at AlphaValue/Baader
- 05/19/23 Mizuho
- ConocoPhillips price target lowered to $126 from $128 at Mizuho
- 05/18/23 Piper Sandler
- ConocoPhillips price target raised to $149 from $140 at Piper Sandler
- 05/15/23 Morgan Stanley
- ConocoPhillips price target raised to $124 from $122 at Morgan Stanley
- 05/01/23 Goldman Sachs
- Exxon Mobil downgraded to Neutral from Buy at Goldman Sachs
- 05/24/23 Citi
- Citi opens 'downside catalyst watch' on Shell into capital markets day
- 05/18/23 Piper Sandler
- Shell price target lowered to $75 from $77 at Piper Sandler
- 04/20/23 Piper Sandler
- Shell price target raised to $77 from $75 at Piper Sandler
- 04/19/23 JPMorgan
- Shell price target lowered to 2,950 GBp from 3,000 GBp at JPMorgan
- 05/19/23 Deutsche Bank
- TotalEnergies price target raised to EUR 59.80 from EUR 56.20 at Deutsche Bank
- 05/18/23 Piper Sandler
- TotalEnergies price target lowered to $68 from $69 at Piper Sandler
- 04/19/23 JPMorgan
- TotalEnergies price target lowered to EUR 69 from EUR 73 at JPMorgan
- 04/11/23 Redburn
- TotalEnergies upgraded to Neutral from Sell at Redburn
- 06/01/23 RBC Capital
- Exxon Mobil downgraded to Sector Perform from Outperform at RBC Capital
- 05/19/23 Mizuho
- Exxon Mobil price target lowered to $130 from $147 at Mizuho
- 05/18/23 Piper Sandler
- Exxon Mobil price target raised to $145 from $134 at Piper Sandler
- 05/15/23 Jefferies
- Exxon Mobil price target lowered to $140 from $148 at Jefferies
- 06/01/23 RBC Capital
- Chevron upgraded to Outperform from Sector Perform at RBC Capital
- 05/31/23 JPMorgan
- Chevron upgraded to Neutral from Underweight at JPMorgan
- 05/24/23 Mizuho
- Chevron price target raised to $202 from $196 at Mizuho
- 05/24/23 Mizuho
- PDC Energy downgraded to Neutral from Buy at Mizuho
- 04/28/23
- Exxon Mobil reports Q1 adjusted EPS $2.83, consensus $2.59
- 04/27/23
- Notable companies reporting before tomorrow's open
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 02/08/23
- TotalEnergies reports Q4 EPS $2.97, consensus $3.03
- 04/06/23
- Shell sees Q1 corporate adjusted earnings loss of ($0.9B)-($1.2B)
- 02/02/23
- Shell reports Q4 adjusted EPS $1.39 vs. 83c last year
- 04/28/23
- Chevron reports Q1 adjusted EPS $3.55, consensus $3.41
- 01/27/23
- Chevron reports Q4 adjusted EPS $4.09, consensus $4.38
- 05/04/23
- ConocoPhillips reports Q1 EPS $2.38, consensus $2.10
- 05/03/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- ConocoPhillips reports Q4 EPS $2.71, consensus $2.81
- 05/02/23
- BP reports Q1 EPS $1.66, consensus $1.40
- 02/07/23
- BP reports Q4 EPS $1.59, consensus $1.67
- 06/02/23
- Exxon, Chevron in advanced talks to drill for gas in Algeria, WSJ reports
- 05/26/23
- Four bidders compete to buy Exxon LNG terminal stake in Italy, Reuters reports
- 04/13/23
- TotalEnergies weighing bid for Neptune Energy, Bloomberg says
- 04/13/23
- TotalEnergies weighing bid for $5B E&P company Neptune, Bloomberg says
- 05/17/23
- Shell planning sale of French floating wind developer Eolfi, Bloomberg says
- 05/17/23
- Shell plans sale of French floating wind power unit EOLFI, Bloomberg says
- 04/24/23
- State-law climate suits against oil companies to proceed, WSJ reports
- 04/06/23
- Buyout firm EnCap ponders nearly $3B of Permian asset sales, Reuters reports
- 04/02/23
- OPEC+ announces surprise oil production cut, Bloomberg says
- 06/02/23
- OPEC+ unlikely to agree on further oil supply reductions Sunday, Reuters says
- 05/21/23
- IEA expects no impact on oil supply by price cap enforcement, Reuters says
- 05/05/23
- BP explores sale of two firms owned by venture unit, Sky reports
- 04/25/23
- BP, Linde in talks over natgas supply for blue hydrogen project, Bloomberg says
- 06/02/23
- What You Missed On Wall Street On Friday
- 06/02/23
- What You Missed On Wall Street This Morning
- 06/01/23
- What You Missed On Wall Street On Thursday
- 06/01/23
- What You Missed On Wall Street This Morning
- 04/13/23
- What You Missed On Wall Street On Thursday
- 04/13/23
- What You Missed On Wall Street This Morning
- 04/04/23
- What You Missed On Wall Street On Tuesday
- 04/06/23
- Fly Intel: Pre-market Movers
- 02/28/23
- What You Missed On Wall Street On Tuesday
- 05/26/23
- What You Missed On Wall Street On Friday
- 03/13/23
- What You Missed On Wall Street This Morning
- 04/24/23
- Fly Intel: Pre-market Movers
- 04/03/23
- What You Missed On Wall Street On Monday
- 04/03/23
- What You Missed On Wall Street This Morning
- 03/23/23
- What You Missed On Wall Street This Morning
- 04/28/23
- Unusually active option classes on open April 28th
- 12/07/22
- Exxon Mobil put buyer realizes 12% same-day gains
- 04/21/23
- Largest borrow rate increases among liquid names
- 05/31/23
- Shell PLC put volume heavy and directionally bearish
- 05/25/23
- Shell PLC put volume heavy and directionally bearish
- 05/24/23
- Shell PLC put volume heavy and directionally bearish
- 03/17/23
- Shell PLC put volume heavy and directionally bearish
- 05/10/23
- Chevron call volume above normal and directionally bullish
- 03/15/23
- Chevron put volume heavy and directionally bearish
- 03/10/23
- Early notable gainers among liquid option names on March 10th
- 01/27/23
- Unusually active option classes on open January 27th
- 05/16/23
- ConocoPhillips put volume heavy and directionally bearish
- 04/05/23
- ConocoPhillips call volume above normal and directionally bullish
- 04/03/23
- Early notable gainers among liquid option names on April 3rd
- 04/03/23
- Unusually active option classes on open April 3rd
- 06/02/23
- Unusually active option classes on open June 2nd
- 05/04/23
- BP call volume above normal and directionally bullish
- 05/04/23
- Unusually active option classes on open May 4th
- 05/02/23
- Unusually active option classes on open May 2nd
|
|
Periodicals
|
The past three months saw… ShowHide Related Items >><< - 06/01/23
- J.P. Morgan launches Payments Partner Network powered by Salesforce Cloud
- 05/23/23
- Climb Global signs $50M credit facility with JPMorgan Chase
- 05/22/23
- Tegna announces $300M ASR agreement with JPMorgan Chase Bank
- 05/22/23
- Dimon says 'everybody should be prepared for higher rates from here'
- 05/23/23
- Citizens Bank to pay $9M penalty to CFPB for unlawful credit card servicing
- 05/23/23
- Citizens Financial comments on CFPB settlement
- 05/11/23
- PacWest Bancorp down 21% after detailing deposit losses in early May
- 05/03/23
- Citizens Bank raises prime lending rate to 8.25% from 8%
- 05/23/23 Morgan Stanley
- JPMorgan price target raised to $160 from $157 at Morgan Stanley
- 05/15/23 Jefferies
- JPMorgan price target lowered to $149 from $152 at Jefferies
- 05/12/23 Citi
- State Street, BNY Mellon hurt most from FDIC proposal, says Citi
- 05/12/23 Evercore ISI
- JPMorgan price target lowered to $151 from $155 at Evercore ISI
- 04/20/23 RBC Capital
- Citizens Financial price target raised to $52 from $48 at RBC Capital
- 04/20/23 DA Davidson
- Citizens Financial price target lowered to $37 from $40 at DA Davidson
- 04/20/23 Credit Suisse
- Citizens Financial price target lowered to $35 from $44 at Credit Suisse
- 05/22/23
- JPMorgan now sees FY NII ex-Markets $84B due to First Republic
- 04/14/23
- JPMorgan reports Q1 EPS $4.10, consensus $3.41
- 04/13/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 04/19/23
- Citizens Financial reports Q1 underlying EPS $1.10, consensus $1.13
- 04/19/23
- Citizens Financial reports Q1 underlying EPS $1.10, consensus $1.13
- 04/18/23
- Notable companies reporting before tomorrow's open
- 06/01/23
- JPMorgan plans closure of 21 First Republic branches, Reuters reports
- 06/01/23
- JPMorgan CEO Dimon denies contact with Epstein, NY Times reports
- 05/26/23
- JPMorgan cut 500 positions this week, CNBC reports
- 05/26/23
- JPMorgan CEO set to be deposed in Epstein suits, CNBC reports
- 04/30/23
- First Republic deal expected by Sunday night, Reuters reports
- 03/29/23
- Citizens Financial investigated in MA for sales of savings product, WSJ reports
- 03/24/23
- Citizens Financial working on bid for SVB Private, Reuters reports
- 06/01/23
- What You Missed On Wall Street This Morning
- 05/26/23
- What You Missed On Wall Street On Friday
- 05/26/23
- What You Missed On Wall Street This Morning
- 05/25/23
- What You Missed On Wall Street On Thursday
- 04/19/23
- What You Missed On Wall Street On Wednesday
- 04/19/23
- What You Missed On Wall Street This Morning
- 04/19/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
- 04/14/23
- Early notable gainers among liquid option names on April 14th
- 04/14/23
- Unusually active option classes on open April 14th
- 03/10/23
- Unusually active option classes on open March 10th
- 01/19/23
- JPMorgan put buyer realizes 24% same-day gains
- 05/31/23
- Citizens Financial put volume heavy and directionally bearish
- 05/02/23
- Citizens Financial put volume heavy and directionally bearish
- 04/28/23
- Citizens Financial call volume above normal and directionally bullish
- 03/31/23
- Citizens Financial call volume above normal and directionally bullish
|
|
Periodicals
| ShowHide Related Items >><< - $186.48 /
+7.435 (+4.15%) - 05/01/23
- BAE Systems, Eaton collaborate on electric drive solutions
- 04/24/23
- Eaton acquires 49% stake in Jiangsu Ryan Electrical Co.
- 03/28/23
- Waters Eaton appoints Fearon to board of directors
- 03/24/23
- Charge Enterprises, Eaton announce strategic collaboration
- $186.48 /
+7.435 (+4.15%) - 05/11/23 UBS
- Eaton price target raised to $210 from $205 at UBS
- 05/09/23 Evercore ISI
- Eaton price target raised to $221 from $201 at Evercore ISI
- 05/03/23 Mizuho
- Eaton price target raised to $180 from $168 at Mizuho
- 05/03/23 Barclays
- Eaton price target raised to $159 from $145 at Barclays
- $186.48 /
+7.435 (+4.15%) - 05/02/23
- Eaton raises FY23 adjusted EPS view to $8.30-$8.50 from $8.04-$8.44
- 05/02/23
- Eaton sees Q2 adjusted EPS $2.04-$2.14, consensus $2.05
- 05/02/23
- Eaton reports Q1 adjusted EPS $1.88, consensus $1.78
- 02/08/23
- Eaton sees Q1 adjusted EPS $1.72-$1.82, consensus $1.80
- $186.48 /
+7.435 (+4.15%) - 12/06/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
